Skip to main content
Journal cover image

Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II.

Publication ,  Journal Article
Filer, D; Patisaul, HB; Schug, T; Reif, D; Thayer, K
Published in: Current opinion in pharmacology
December 2014

Identifying chemicals, beyond those already implicated, to test for potential endocrine disruption is a challenge and high throughput approaches have emerged as a potential tool for this type of screening. This review focused the Environmental Protection Agency's (EPA) ToxCast(TM) high throughput in vitro screening (HTS) program. Utility for identifying compounds was assessed and reviewed by using it to run the recently expanded chemical library (from 309 compounds to 1858) through the ToxPi(TM) prioritization scheme for endocrine disruption. The analysis included metabolic and neuroendocrine targets. This investigative approach simultaneously assessed the utility of ToxCast, and helped identify novel chemicals which may have endocrine activity. Results from this exercise suggest the spectrum of environmental chemicals with potential endocrine activity is much broader than indicated, and that some aspects of endocrine disruption are not fully covered in ToxCast.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Current opinion in pharmacology

DOI

EISSN

1471-4973

ISSN

1471-4892

Publication Date

December 2014

Volume

19

Start / End Page

145 / 152

Related Subject Headings

  • United States Environmental Protection Agency
  • United States
  • Risk Assessment
  • Pharmacology & Pharmacy
  • Models, Theoretical
  • Humans
  • High-Throughput Screening Assays
  • Endocrine Disruptors
  • Databases, Factual
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Filer, D., Patisaul, H. B., Schug, T., Reif, D., & Thayer, K. (2014). Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. Current Opinion in Pharmacology, 19, 145–152. https://doi.org/10.1016/j.coph.2014.09.021
Filer, Dayne, Heather B. Patisaul, Thaddeus Schug, David Reif, and Kristina Thayer. “Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II.Current Opinion in Pharmacology 19 (December 2014): 145–52. https://doi.org/10.1016/j.coph.2014.09.021.
Filer D, Patisaul HB, Schug T, Reif D, Thayer K. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. Current opinion in pharmacology. 2014 Dec;19:145–52.
Filer, Dayne, et al. “Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II.Current Opinion in Pharmacology, vol. 19, Dec. 2014, pp. 145–52. Epmc, doi:10.1016/j.coph.2014.09.021.
Filer D, Patisaul HB, Schug T, Reif D, Thayer K. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. Current opinion in pharmacology. 2014 Dec;19:145–152.
Journal cover image

Published In

Current opinion in pharmacology

DOI

EISSN

1471-4973

ISSN

1471-4892

Publication Date

December 2014

Volume

19

Start / End Page

145 / 152

Related Subject Headings

  • United States Environmental Protection Agency
  • United States
  • Risk Assessment
  • Pharmacology & Pharmacy
  • Models, Theoretical
  • Humans
  • High-Throughput Screening Assays
  • Endocrine Disruptors
  • Databases, Factual
  • Animals